Nancy Paul
University of Toronto
9 Papers
37 Citations
Nancy Paul is an academic researcher from University of Toronto. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 7, co-authored 9 publications.
Chat about Author
Papers
Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
Mark Levine,Kathleen I. Pritchard,Vivien H.C. Bramwell,Lois E. Shepherd,Dongsheng Tu,Nancy Paul +5 more
TL;DR: The previously demonstrated benefit of CEF compared with CMF adjuvant chemotherapy is maintained with longer follow-up in the MA5 trial, and the rates of congestive heart failure and acute leukemia have not changed since the original report.
231
Left ventricular function following adjuvant chemotherapy for breast cancer: The NCIC CTG MA5 experience
Lois E. Shepherd,Wendy R. Parulekar,Kathleen I. Pritchard,Maureen E. Trudeau,Nancy Paul,D. Tu,Mitch Levine +6 more
TL;DR: Changes in cardiac function as measured by a decrease in LVEF are not infrequent in patients after adjuvant therapy, even in the absence of anthracyclines.
11